Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_assertion type Assertion NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_head.
- NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_assertion description "[The clinical and pathologic characteristics of the CD30 TLPDs were similar to those of their extravascular counterparts, including extralymphatic dermal involvement in a subset, DUSP22-IRF4 translocations in half of tested ALK ALCLs, and associated mycosis fungoides in 1; most were skin-limited at baseline and remained so at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_provenance.
- NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_assertion evidence source_evidence_literature NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_provenance.
- NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_assertion SIO_000772 24805854 NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_provenance.
- NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_assertion wasDerivedFrom befree-2016 NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_provenance.
- NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_assertion wasGeneratedBy ECO_0000203 NP1180273.RAvL6-GUGLgVxHMoMRs8w1bymyV3jLUTnXWO98Hq4oI2Q130_provenance.